期刊文献+

浅议帕金森病的早期诊断

原文传递
导出
摘要 帕金森病是一种常见的中老年神经系统变性疾病。近年来,由于生物化学、影像学及基因检测技术的快速发展及其在医学领域的应用,使帕金森病的早期识别成为可能。
作者 石宜乐
出处 《按摩与康复医学》 2011年第11期47-48,共2页 Chinese Manipulation and Rehabilitation Medicine
  • 相关文献

参考文献9

  • 1Chen JJ.Parkinson's disease:health-related quality of life,economic cost,and implications of early treatment[J].Am J Manag Care,2010,16(4):87-93.
  • 2Fearnley JM,Lees A.Ageing and Parkinson's disease:substantia nigra regional selectivity[J].Brain 1991,114:2283-2301.
  • 3Sato S,Mizuno Y,Hattori N.Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease[J].Neurology,2005,64(6):1081-1083.
  • 4Parker WD Jr,Boyson SJ,Parks JK.Abnormalities of the electron transport chain in idiopathic Parkinson's disease[J].Ann Neural,1989,26(6):719-723.
  • 5王坚,李尧华,郑晓立,张燕莉,李昕,于顺,何欣,陈彪.弱阳离子交换纳米磁珠介导的帕金森病血清蛋白质组学的初步研究[J].中华神经科杂志,2009,42(2):98-101. 被引量:4
  • 6Shi M,Caudle WM,Zhang J.Biomarker discovery in neurodegenerative diseasess:a proteomic approach[J].Neurobiol Dis,2009,35(2):157-164.
  • 7Mollenhauer B,Cullen V,Kahn I,et al.Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration[J].EXP Neurol,2008,213(2):315-325.
  • 8Weidong L,Shen C,Jankovic J.Etiopathogenesis of Parkinson disease:a new beginning[J].Neuroscientist,2009,15(1):28-35.
  • 9Morrish PK,Sawle GV,Brooks DJ,et al.Clinical and[18F] dopa PET findings in early Parkinson's disease[J].J Neurol Neurosurg Psychiatry,1995,59(4):597-600.

二级参考文献10

  • 1Fearnley JM, Lees AJ. Ageing and Parkinson' s disease: substantia nigra regional selectivity. Brain, 1991, 114: 2283- 2301.
  • 2Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson' s disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm, 1976, 38: 277- 301.
  • 3Dotzlaw H, Schulz M, Eggert M, et al. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta, 2004, 1696: 121-129.
  • 4Kang X, Xu Y, Wu X, et al. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem, 2005, 51 : 56-64.
  • 5Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson' s Disease Reting Scale: Motor Examination section. Mov Disord, 1998, 13: 633-636.
  • 6de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson ' s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson' s disease. J Neurol Neurosurg Psychiatry, 1997, 62: 10-15.
  • 7Abe T, Isobe C, Murata T, et al. Aheration of 8- hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parksinson ' s disease. Neurosci Lett, 2003, 336 : 105-108.
  • 8Petricoin EF, Belluco C, Araujo RP, et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer, 2006, 6: 961-967.
  • 9McDonald WH, Yates JR 3rd. Shotgun proteomics and biomarker discovery. Dis Markers, 2002, 18: 99-105.
  • 10Gatlin-Bunai CL, Cazares LH, Cooke WE, et al. Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinitycaptured proteins spanning a 100 kDa mass range. J Proteome Res, 2007, 6: 4517-4524.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部